LipidiL Supra Tablets (Fenofibrate)

Adult dose

As fenofibrate, take 160 mg orally once daily immediately after meals. Fenofibrate must be used in conjunction with dietary measures. This medication may have reduced absorption on an empty stomach, so it should be taken immediately after meals.

Child dose

There is currently no clinical data regarding the use of this medication in children.

This drug should not be used in patients with poor liver function. Administration should be avoided in patients with moderate or severe impairment of kidney function, especially in the presence of high serum creatinine levels, due to the risk of rhabdomyolysis, a serious muscle injury. Women who are pregnant or may become pregnant and those who are breastfeeding should not use this medication. Patients who have had allergic reactions to this drug or its components should not be administered this medication. Caution is also necessary for patients with gallbladder disease or those who have experienced photosensitivity reactions while taking similar substances. This drug is not to be administered to children, and patients with biliary sclerosis or pancreatitis should also avoid using this medication. Patients with genetic lactose intolerance should not receive this drug. Patients with mild renal impairment or liver dysfunction, hypoalbuminemia, a history of gallstones, those on anticoagulants, and elderly patients should use this drug with caution. Regular monitoring of liver function tests and blood lipid levels is required during treatment, with adjustments to dosage or discontinuation considered if abnormalities are found. This medication may cause a variety of side effects, including skin rash, itching, photosensitivity reactions, myalgia, dizziness, headache, and gastrointestinal disorders; symptoms should be reported to a physician immediately. Particular caution is warranted if severe myalgia or weakness occurs due to the risk of muscle damage. Drug interactions may arise; particularly patients taking anticoagulants, statins, antidiabetics, and immunosuppressants should consult their physician. Use during pregnancy or lactation should be avoided as it may pose risks to the fetus or newborn. Elderly patients are more likely to have reduced liver and kidney function; hence, they should be monitored frequently through blood tests. There is no specific antidote for overdose, making accurate dosage adherence critical. This drug should be kept out of the reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor (severe allergic reactions), severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes (severe skin reactions), shortness of breath or difficulty breathing, asthma attacks, coughing with fever accompanying respiratory issues (respiratory problems), yellowing of skin or eyes (jaundice), profound lethargy (liver issues), sudden and

Mild side effects

Liver enlargement, cholestatic hepatitis, gallstones, rash, itching, hair loss, weakness, fever, dizziness, headache, peripheral neuropathy, thromboembolism, elevated creatine kinase, myalgia, muscle cramps, joint pain, gastrointestinal disturbances (abdominal pain, nausea, vomiting, diarrhea, abdominal bloating), hematological changes (decreased hemoglobin, leukopenia, eosinophilia, elevated serum creatinine and urea), eosinophilic pneumonia, ventricular arrhythmia, fatigue

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. Moreover, it should be stored at room temperature, ideally between 1 and 30 degrees Celsius, ensuring it is not too hot or too cold.

Appearance

White, oval, controlled-release film-coated tablets. One side is engraved with '160' and the other side has the Fournier logo.

Package unit

30 tablets (10 tablets/PTP × 3)